Arthur Tzianabos - Feb 24, 2022 Form 4 Insider Report for Homology Medicines, Inc. (FIXX)

Role
President & CEO, Director
Signature
/s/ W. Bradford Smith, Attorney-in-Fact for Arthur O. Tzianabos
Stock symbol
FIXX
Transactions as of
Feb 24, 2022
Transactions value $
$0
Form type
4
Date filed
2/28/2022, 03:05 PM
Previous filing
Jan 12, 2022
Next filing
Jun 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FIXX Employee Stock Option (Right to Buy) Award $0 +350K $0.00 350K Feb 24, 2022 Common Stock 350K $2.71 Direct F1
transaction FIXX Restricted Stock Units Award $0 +58K $0.00 58K Feb 24, 2022 Common Stock 58K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 48 substantially equal monthly installments on the first day of each calendar month following January 1, 2022.
F2 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.
F3 The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025.